1. Novikov, V.V, Baryshnikov, A.Yu., and Karaulov, A.V., Soluble Forms of Membrane Antigens of Immune System Cells, Immunologiya, 2007, no. 4, p. 249.
2. Costs, E., Lima, M., Alves, J., et al., Inflammation, T-Cell Phenotype, and Inflammatory Cytokines in Chronic Kidney Disease Patients Under Hemodialysis and Its Relationship to Resistance to Recombinant Human Erythropoietin Therapy, J. Clin. Immunol., 2008, vol. 28, no. 3, p. 268.
3. Mller, H.J., Nielsen, M.J., Maniecki, M.B., et al., Soluble Macrophage-Derived CD163: a Homogenous Ectodomain Protein with a Dissociable Haptoglobulin-Hemoglobin Binding, Immunology, 2010, vol. 215, no. 5, p. 406.
4. Kuptsova, N.V., Ryabinina, Z.V., Tyutcheva, O.V., et al., Fas-FasL Interaction Causes Immunodeficiency in Children with Atopic Bronchial Asthma, Fund. Issled., 2010, vol. 25, no. 1, p. 58.
5. An, H., Chandra, V., Pirairo, B., et al., Soluble LILRA3, a Potential Natural Anti-Inflammatory Protein, Is Increased in Patients with Rheumatoid Arthritis and Is Tightly Regulated by Interleukin 10, Tumor Necrosis Factors- and Interferon, J. Rheumatol., 2010, vol. 37, no. 8, p. 1596.